Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117028972 | 11702897 | 2 | F | 20150515 | 20160721 | 20151105 | 20160801 | EXP | DE-ELI_LILLY_AND_COMPANY-DE201510008583 | ELI LILLY AND CO | 76.00 | YR | F | Y | 0.00000 | 20160729 | CN | GB | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117028972 | 11702897 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Oral | 5 MG, QD | N | U | 20592 | 5 | MG | QD | |||||
| 117028972 | 11702897 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 2.5 MG, QD | N | U | 20592 | 2.5 | MG | QD | |||||
| 117028972 | 11702897 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 5 MG, QD | N | U | 20592 | 5 | MG | QD | |||||
| 117028972 | 11702897 | 4 | SS | VENLAFAXIN | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, QD | N | U | 0 | 37.5 | MG | QD | |||||
| 117028972 | 11702897 | 5 | SS | VENLAFAXIN | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, QD | N | U | 0 | 75 | MG | QD | |||||
| 117028972 | 11702897 | 6 | SS | VENLAFAXIN | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 112.5 MG, QD | N | U | 0 | 112.5 | MG | QD | |||||
| 117028972 | 11702897 | 7 | SS | PREDNISOLON /00016201/ | PREDNISOLONE | 1 | Oral | 1 DF, QD | U | U | 0 | 1 | DF | QD | |||||
| 117028972 | 11702897 | 8 | SS | PREDNISOLON /00016201/ | PREDNISOLONE | 1 | Unknown | 5 MG, UNKNOWN | U | U | 0 | 5 | MG | ||||||
| 117028972 | 11702897 | 9 | SS | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | N | U | 0 | 1 | DF | QD | |||||
| 117028972 | 11702897 | 10 | C | DENOSUMAB | DENOSUMAB | 1 | 0 | ||||||||||||
| 117028972 | 11702897 | 11 | C | METHOTREXATE (METHOTREXATE SODIUM) | METHOTREXATE SODIUM | 1 | Oral | 10 MG, QD | N | U | 0 | 10 | MG | QD | |||||
| 117028972 | 11702897 | 12 | C | METHOTREXATE (METHOTREXATE SODIUM) | METHOTREXATE SODIUM | 1 | Unknown | 15 MG, WEEKLY (1/W) | N | U | 0 | 15 | MG | /wk | |||||
| 117028972 | 11702897 | 13 | C | TOVIAZ | FESOTERODINE FUMARATE | 1 | Oral | 8 MG, QD | N | U | 0 | 8 | MG | QD | |||||
| 117028972 | 11702897 | 14 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 1 MG, UNKNOWN | U | U | 0 | 1 | MG | ||||||
| 117028972 | 11702897 | 15 | C | AMITRIPTYLLINE | AMITRIPTYLINE | 1 | Unknown | N | 0 | ||||||||||
| 117028972 | 11702897 | 16 | C | DOXEPIN | DOXEPIN | 1 | U | 0 | |||||||||||
| 117028972 | 11702897 | 17 | C | DABIGATRAN | DABIGATRAN | 1 | Unknown | 200 MG, WEEKLY (1/W) | U | 0 | 200 | MG | /wk | ||||||
| 117028972 | 11702897 | 18 | C | PANTOPRAZOL | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117028972 | 11702897 | 1 | Sleep disorder |
| 117028972 | 11702897 | 2 | Depressed mood |
| 117028972 | 11702897 | 4 | Antidepressant therapy |
| 117028972 | 11702897 | 7 | Rheumatoid arthritis |
| 117028972 | 11702897 | 9 | Product used for unknown indication |
| 117028972 | 11702897 | 10 | Product used for unknown indication |
| 117028972 | 11702897 | 11 | Rheumatoid arthritis |
| 117028972 | 11702897 | 13 | Product used for unknown indication |
| 117028972 | 11702897 | 14 | Anxiolytic therapy |
| 117028972 | 11702897 | 15 | Sleep disorder |
| 117028972 | 11702897 | 16 | Sleep disorder |
| 117028972 | 11702897 | 17 | Anticoagulant therapy |
| 117028972 | 11702897 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117028972 | 11702897 | LT |
| 117028972 | 11702897 | DE |
| 117028972 | 11702897 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117028972 | 11702897 | Fracture | |
| 117028972 | 11702897 | Generalised tonic-clonic seizure | |
| 117028972 | 11702897 | Haemorrhage | |
| 117028972 | 11702897 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117028972 | 11702897 | 1 | 20150512 | 20150512 | 0 | |
| 117028972 | 11702897 | 2 | 20150513 | 20150515 | 0 | |
| 117028972 | 11702897 | 3 | 20150515 | 0 | ||
| 117028972 | 11702897 | 4 | 20150421 | 20150426 | 0 | |
| 117028972 | 11702897 | 5 | 20150427 | 20150504 | 0 | |
| 117028972 | 11702897 | 6 | 20051105 | 20150515 | 0 | |
| 117028972 | 11702897 | 7 | 201410 | 20150515 | 0 | |
| 117028972 | 11702897 | 8 | 20150515 | 0 | ||
| 117028972 | 11702897 | 9 | 201410 | 20150515 | 0 | |
| 117028972 | 11702897 | 11 | 20150512 | 0 | ||
| 117028972 | 11702897 | 13 | 20150515 | 0 | ||
| 117028972 | 11702897 | 14 | 20150409 | 20150513 | 0 |